Related Experiment Video
Updated: Feb 1, 2026

A Rapid Method to Confine and Safely Handle Bees in the Field
Published on: August 23, 2024
Handling Missing Dosing History in Population Pharmacokinetic Modeling: An Extension to MDM Method
1Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Abstract:
A major challenge in population pharmacokinetic modeling is handling data with missing or potentially incorrect dosing records. Leaving such records untreated or "commented out" will cause bias in parameter estimates. Several approaches were previously developed to address this challenge. Published in 2004, the missing dose method (MDM) demonstrated its robustness in handling missing dosing history in pharmacokinetic (PK) modeling. In this study, we presented two new extensions: a modified MDM method (MDM2) and a compartment initialization method (CIM). Their performance was examined with a large batch of simulated PK studies. For each method, 8,000 models were run, including different model structures, dosing routes, and missing dosing record scenarios. Both MDM2 and CIM exhibited robust performance and improved parameter estimation results. Specifically, CIM consistently outperformed other methods in fixed-effect and random-effect PK parameter estimation. The new methods demonstrate great potential in addressing missing dosing records challenges in PK analysis.
Related Concept Videos
What is Evolutionary History?
Analysis of Population Pharmacokinetic Data
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Dose Size and Dosing Frequency: Determination Methods
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

